Suchergebnisse - "Carroll, Miles W"

PubPharm (135)

1

Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery

enthalten in: Clinical and experimental immunology | 2024

von Ali, M. | Longet, S. | Neale, I. | +31

2

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents

enthalten in: iScience | 2023

von Ratcliffe, H. | Tiley, K. | Longet, S. | +38

3

Corrigendum : Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2

enthalten in: The Journal of general virology | 2023

von Thursz, M. | Sadiq, F. | Tree, J. | +10

ErratumFor: J Gen Virol. 2023 Jul;104(7):. - PMID 37432877

4

Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2

enthalten in: The Journal of general virology | 2023

von Thursz, M. | Sadiq, F. | Tree, J. | +10

ErratumIn: J Gen Virol. 2023 Jul;104(7):. - PMID 37493135

5

The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection

enthalten in: Genome biology | 2023

von Goldswain, H. | Dong, X. | Penrice-Randal, R. | +127

6

Influence of Landscape Patterns on Exposure to Lassa Fever Virus, Guinea

enthalten in: Emerging infectious diseases | 2023

von Longet, S. | Leggio, C. | Bore, J. | +13

7

Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine

enthalten in: Journal of medicinal chemistry | 2023

von Brewitz, L. | Dumjahn, L. | Zhao, Y. | +13

8

Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform

enthalten in: iScience | 2023

von Bojkova, D. | Reus, P. | Panosch, L. | +22

9

Pre-clinical models to define correlates of protection for SARS-CoV-2

enthalten in: Frontiers in immunology | 2023

von Brady, C. | Tipton, T. | Longet, S. | +1

10

Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial

enthalten in: Nature communications | 2022

von Donovan-Banfield, I. | Penrice-Randal, R. | Goldswain, H. | +31

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]